Karachi: BF Biosciences Limited has announced its application for listing on the Main Board of the Pakistan Stock Exchange (PSX), inviting public comments on its draft prospectus. The total issue size of the Initial Public Offering (IPO) consists of 25 million Ordinary Shares at a par value of PKR 3 each. The shares are being offered using the Book Building Method at a Floor Price of PKR 55 per share, according to the announcement made available on the PSX website.
The company's move to go public was facilitated by Arif Habib Limited, which is serving as the Lead Manager to the Issue. According to information available from the Pakistan Stock Exchange (PSX), the draft prospectus has been placed on the PSX website for public review under the caption "Public Comments on Draft Prospectus of BF Biosciences Limited." This action follows the guidelines set by Circular No. 16 of 2023, issued on November 8, 2023, by the Securities and Exchange Commission of Pakistan (SECP).
Interested parties are encouraged to review the draft prospectus and provide their written feedback. Comments can be submitted to PSX via email at comments.draftprospectus@psx.com.pk until the close of business on August 15, 2024. This public engagement process highlights the transparency and regulatory adherence of BF Biosciences Limited as it prepares to join the ranks of publicly traded companies.